RU2008131066A - Фармацевтическая композиция, содержащая белок nma0939 - Google Patents
Фармацевтическая композиция, содержащая белок nma0939 Download PDFInfo
- Publication number
- RU2008131066A RU2008131066A RU2008131066/13A RU2008131066A RU2008131066A RU 2008131066 A RU2008131066 A RU 2008131066A RU 2008131066/13 A RU2008131066/13 A RU 2008131066/13A RU 2008131066 A RU2008131066 A RU 2008131066A RU 2008131066 A RU2008131066 A RU 2008131066A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- protein
- antigens
- nma0939
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 26
- 108090000623 proteins and genes Proteins 0.000 title claims abstract 8
- 102000004169 proteins and genes Human genes 0.000 title claims abstract 7
- 229920001282 polysaccharide Polymers 0.000 claims abstract 12
- 239000005017 polysaccharide Substances 0.000 claims abstract 12
- 102000036639 antigens Human genes 0.000 claims abstract 10
- 108091007433 antigens Proteins 0.000 claims abstract 10
- 150000004676 glycans Chemical class 0.000 claims abstract 10
- 239000000427 antigen Substances 0.000 claims abstract 8
- 241000588650 Neisseria meningitidis Species 0.000 claims abstract 4
- 230000001580 bacterial effect Effects 0.000 claims abstract 4
- 208000015181 infectious disease Diseases 0.000 claims abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 4
- 230000001681 protective effect Effects 0.000 claims abstract 4
- 229960005486 vaccine Drugs 0.000 claims abstract 4
- 241000894006 Bacteria Species 0.000 claims abstract 2
- 241000588653 Neisseria Species 0.000 claims abstract 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims abstract 2
- 102000007079 Peptide Fragments Human genes 0.000 claims abstract 2
- 108010033276 Peptide Fragments Proteins 0.000 claims abstract 2
- 239000002671 adjuvant Substances 0.000 claims abstract 2
- 230000001939 inductive effect Effects 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims abstract 2
- 210000004400 mucous membrane Anatomy 0.000 claims abstract 2
- 238000007911 parenteral administration Methods 0.000 claims abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 2
- 238000001514 detection method Methods 0.000 claims 2
- 208000037941 meningococcal disease Diseases 0.000 claims 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU2005-0279 | 2005-12-29 | ||
| CU20050279A CU23549A1 (es) | 2005-12-29 | 2005-12-29 | Composiciones farmacéuticas que contienen la proteína nma0939 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008131066A true RU2008131066A (ru) | 2010-02-10 |
Family
ID=38218331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008131066/13A RU2008131066A (ru) | 2005-12-29 | 2006-12-28 | Фармацевтическая композиция, содержащая белок nma0939 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090208521A1 (enExample) |
| EP (1) | EP1977761A2 (enExample) |
| KR (1) | KR20080081198A (enExample) |
| CN (1) | CN101443037A (enExample) |
| AR (1) | AR058735A1 (enExample) |
| AU (1) | AU2006331224A1 (enExample) |
| BR (1) | BRPI0620867A2 (enExample) |
| CA (1) | CA2633424A1 (enExample) |
| CU (1) | CU23549A1 (enExample) |
| NO (1) | NO20083318L (enExample) |
| RU (1) | RU2008131066A (enExample) |
| WO (1) | WO2007073705A2 (enExample) |
| ZA (1) | ZA200805355B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7104027B2 (ja) * | 2016-09-02 | 2022-07-20 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 淋菌に対するワクチン |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA01011047A (es) * | 1999-04-30 | 2003-10-14 | Chiron Corp | Secuencias genomicas de neisseria y metodos para su uso. |
| GB0103424D0 (en) * | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| DK2255826T3 (en) * | 2002-08-02 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Neisserial vaccine compositions comprising a combination of antigens. |
| CU23236A1 (es) * | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P |
-
2005
- 2005-12-29 CU CU20050279A patent/CU23549A1/es active IP Right Grant
-
2006
- 2006-12-26 AR ARP060105777A patent/AR058735A1/es unknown
- 2006-12-28 WO PCT/CU2006/000019 patent/WO2007073705A2/es not_active Ceased
- 2006-12-28 AU AU2006331224A patent/AU2006331224A1/en not_active Abandoned
- 2006-12-28 US US12/097,895 patent/US20090208521A1/en not_active Abandoned
- 2006-12-28 CA CA002633424A patent/CA2633424A1/en not_active Abandoned
- 2006-12-28 RU RU2008131066/13A patent/RU2008131066A/ru not_active Application Discontinuation
- 2006-12-28 BR BRPI0620867-3A patent/BRPI0620867A2/pt not_active IP Right Cessation
- 2006-12-28 CN CNA200680049521XA patent/CN101443037A/zh active Pending
- 2006-12-28 KR KR1020087018520A patent/KR20080081198A/ko not_active Withdrawn
- 2006-12-28 EP EP06846929A patent/EP1977761A2/en not_active Withdrawn
-
2008
- 2008-06-19 ZA ZA200805355A patent/ZA200805355B/xx unknown
- 2008-07-28 NO NO20083318A patent/NO20083318L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CU23549B7 (enExample) | 2010-07-20 |
| AU2006331224A1 (en) | 2007-07-05 |
| CA2633424A1 (en) | 2007-07-05 |
| BRPI0620867A2 (pt) | 2011-11-29 |
| ZA200805355B (en) | 2009-04-29 |
| CN101443037A (zh) | 2009-05-27 |
| KR20080081198A (ko) | 2008-09-08 |
| WO2007073705A2 (es) | 2007-07-05 |
| CU23549A1 (es) | 2010-07-20 |
| AR058735A1 (es) | 2008-02-20 |
| WO2007073705A3 (es) | 2007-09-13 |
| US20090208521A1 (en) | 2009-08-20 |
| NO20083318L (no) | 2008-09-26 |
| EP1977761A2 (en) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL260135A (en) | Preparations and methods of neisseria meningitidis | |
| CN101745104B (zh) | 含有复合佐剂的结核亚单位疫苗 | |
| FI3501534T3 (fi) | Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia | |
| YU24391A (sh) | Poboljšana meningokokna polisaharid kon-jugovana vakcina | |
| WO2004011027A1 (en) | Chimeric multivalent polysaccharide conjugate vaccines | |
| MX2007003402A (es) | Composicion inmunogena para su uso en vacunacion contra estafilococos. | |
| DK1898948T3 (da) | Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans | |
| JP2010516713A5 (enExample) | ||
| Whitlock et al. | Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge | |
| RU2011140858A (ru) | Конъюгаты гаптен-носитель, содержащие в качестве носителя бактериальные токсины, обладающие сигнальным пептидом, и их применение в иммуногенных композициях | |
| CA2285018A1 (en) | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof | |
| JP2016522259A5 (enExample) | ||
| JP2007516181A5 (enExample) | ||
| EP2364725A3 (en) | Immunization method against neisseria meningitidis serogroups a and c | |
| CN105555305A (zh) | 用于生产膜抗原的一般化模块的突变体细菌 | |
| EP3880240A2 (en) | Clostridium difficile multi-component vaccine | |
| RU2009139262A (ru) | Улучшенные вакцины против bordetella pertussis на основе мутантных гликозилтрансфераз lps | |
| RU2008131066A (ru) | Фармацевтическая композиция, содержащая белок nma0939 | |
| Del Giudice | Hsp70: a carrier molecule with built-in adjuvanticity | |
| WO2022178196A1 (en) | Meningococcal b recombinant vaccine | |
| BRPI0516770A (pt) | vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente | |
| RU2006123414A (ru) | Белок nmb0928 и его применение в фармацевтических композициях | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| GB2442408A (en) | Vaccine adjuvants | |
| BRPI0516372A (pt) | conjugados de polissacarìdeo-proteìna derivatizados meningocócicos multivalentes e vacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110120 |